NASDAQ:EKSO - Ekso Bionics Stock Price, Price Target & More

$1.6150 -0.01 (-0.62 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$1.6150
Today's Range$1.61 - $1.66
52-Week Range$0.99 - $4.77
Volume105,974 shs
Average Volume769,072 shs
Market Capitalization$98.15 million
P/E Ratio-1.81
Dividend YieldN/A
Beta-0.6

About Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics logoEkso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company's Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry General industrial machinery,
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:EKSO
CUSIPN/A
Phone510-984-1761

Debt

Debt-to-Equity Ratio0.23%
Current Ratio3.81%
Quick Ratio3.48%

Price-To-Earnings

Trailing P/E Ratio-1.81
Forward P/E Ratio-3.36
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.35 million
Price / Sales13.23
Cash FlowN/A
Price / CashN/A
Book Value$0.36 per share
Price / Book4.49

Profitability

EPS (Most Recent Fiscal Year)($0.89)
Net Income$-29,120,000.00
Net Margins-396.04%
Return on Equity-246.15%
Return on Assets-107.72%

Miscellaneous

Employees92
Outstanding Shares60,220,000

How to Become a New Pot Stock Millionaire

Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Shares of Ekso Bionics reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

How were Ekso Bionics' earnings last quarter?

Ekso Bionics (NASDAQ:EKSO) announced its quarterly earnings data on Tuesday, March, 13th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by $0.05. The company had revenue of $2.45 million for the quarter. Ekso Bionics had a negative return on equity of 246.15% and a negative net margin of 396.04%. View Ekso Bionics' Earnings History.

When is Ekso Bionics' next earnings date?

Ekso Bionics is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for Ekso Bionics.

What price target have analysts set for EKSO?

1 analysts have issued 12 month price targets for Ekso Bionics' stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate Ekso Bionics' stock price to reach $4.00 in the next twelve months. View Analyst Ratings for Ekso Bionics.

Who are some of Ekso Bionics' key competitors?

Who are Ekso Bionics' key executives?

Ekso Bionics' management team includes the folowing people:
  • Mr. Jack Peurach, Pres, CEO & Director (Age 52)
  • Mr. Maximilian Scheder-Bieschin, Chief Financial Officer (Age 56)
  • Mr. Russell L. DeLonzor, Chief Operating Officer (Age 56)
  • Mr. Gregory Davault, Chief Marketing Officer (Age 50)
  • Mr. Ruediger Hausherr, Pres of Europe

Has Ekso Bionics been receiving favorable news coverage?

Media headlines about EKSO stock have been trending somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Ekso Bionics earned a daily sentiment score of 0.11 on Accern's scale. They also gave media headlines about the company an impact score of 45.09 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of Ekso Bionics?

Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $1.6150.

How big of a company is Ekso Bionics?

Ekso Bionics has a market capitalization of $98.15 million and generates $7.35 million in revenue each year. The company earns $-29,120,000.00 in net income (profit) each year or ($0.89) on an earnings per share basis. Ekso Bionics employs 92 workers across the globe.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]


MarketBeat Community Rating for Ekso Bionics (EKSO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  175 (Vote Outperform)
Underperform Votes:  151 (Vote Underperform)
Total Votes:  326
MarketBeat's community ratings are surveys of what our community members think about Ekso Bionics and other stocks. Vote "Outperform" if you believe EKSO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EKSO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Ekso Bionics (NASDAQ:EKSO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Ekso Bionics in the last 12 months. Their average twelve-month price target is $4.00, suggesting that the stock has a possible upside of 147.68%. The high price target for EKSO is $4.00 and the low price target for EKSO is $4.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $4.00$4.00$4.00$4.00
Price Target Upside: 147.68% upside145.40% upside145.40% upside145.40% upside

Ekso Bionics (NASDAQ:EKSO) Consensus Price Target History

Price Target History for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ:EKSO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/15/2017B. RileyReiterated RatingBuy$4.00HighView Rating Details
10/14/2016SunTrust BanksInitiated CoverageBuyN/AView Rating Details
7/31/2016Rodman & RenshawReiterated RatingBuyN/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Ekso Bionics (NASDAQ:EKSO) Earnings History and Estimates Chart

Earnings by Quarter for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ:EKSO) Earnings Estimates

2018 EPS Consensus Estimate: ($0.93)
2019 EPS Consensus Estimate: ($0.38)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.39)($0.07)($0.23)
Q2 20182($0.39)($0.09)($0.24)
Q3 20182($0.37)($0.08)($0.23)
Q4 20182($0.36)($0.10)($0.23)
Q1 20191($0.09)($0.09)($0.09)
Q2 20191($0.10)($0.10)($0.10)
Q3 20191($0.09)($0.09)($0.09)
Q4 20191($0.10)($0.10)($0.10)

Ekso Bionics (NASDAQ EKSO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018($0.07)N/AView Earnings Details
3/13/2018Q4 2017($0.10)($0.15)$2.45 millionViewN/AView Earnings Details
11/8/2017Q3 2017($0.13)($0.18)$2.40 million$1.60 millionViewN/AView Earnings Details
8/7/2017Q2 2017($0.32)($0.32)$2.00 million$1.87 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.41)($0.38)$2.38 million$1.44 millionViewListenView Earnings Details
3/7/2017Q4 2016($0.39)($0.41)$2.59 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.41)($0.51)$1.79 million$1.60 millionViewN/AView Earnings Details
7/28/2016Q2 2016($0.28)($0.71)$2.14 million$1.55 millionViewN/AView Earnings Details
5/10/2016Q1 2016($0.63)$8.49 millionViewN/AView Earnings Details
3/14/2016Q4 2015($0.63)$2.54 million$1.94 millionViewN/AView Earnings Details
11/5/2015Q3 2015($0.04)($0.05)$2.55 million$2.92 millionViewN/AView Earnings Details
8/11/2015Q2 2015($0.04)($0.06)$2.00 million$2.11 millionViewN/AView Earnings Details
5/7/2015Q1 2015($0.35)($0.28)$1.76 million$1.69 millionViewN/AView Earnings Details
3/17/2015Q4 2014($0.03)($0.06)$1.48 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Ekso Bionics (NASDAQ:EKSO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Ekso Bionics (NASDAQ EKSO) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.32%
Institutional Ownership Percentage: 38.69%
Insider Trading History for Ekso Bionics (NASDAQ:EKSO)
Institutional Ownership by Quarter for Ekso Bionics (NASDAQ:EKSO)

Ekso Bionics (NASDAQ EKSO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/22/2017Russ AngoldInsiderSell50,000$3.51$175,500.00View SEC Filing  
9/14/2017Amy Mcbride WendellDirectorBuy16,264$1.23$20,004.7216,264View SEC Filing  
9/8/2017Thomas LoobyCEOBuy15,000$1.13$16,950.0020,315View SEC Filing  
9/7/2017Max Scheder-BieschinCFOBuy10,000$1.13$11,300.0032,371View SEC Filing  
8/23/2017Russ AngoldInsiderSell9,352$1.33$12,438.16241,326View SEC Filing  
8/16/2017Russ AngoldInsiderSell28,254$1.53$43,228.62250,678View SEC Filing  
8/15/2017Russ AngoldInsiderSell221,746$1.55$343,706.30400,678View SEC Filing  
11/11/2016Max Scheder-BieschinCFOBuy1,000$4.00$4,000.009,817View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Ekso Bionics (NASDAQ EKSO) News Headlines

Source:
DateHeadline
These bionic vests give factory workers super strength and help prevent injuriesThese bionic vests give factory workers super strength and help prevent injuries
finance.yahoo.com - April 20 at 5:30 PM
Analysts Set Expectations for Ekso Bionics Holdings, Inc.s Q1 2019 Earnings (EKSO)Analysts Set Expectations for Ekso Bionics Holdings, Inc.'s Q1 2019 Earnings (EKSO)
www.americanbankingnews.com - April 16 at 2:44 AM
-$0.07 Earnings Per Share Expected for Ekso Bionics Holdings, Inc. (EKSO) This Quarter-$0.07 Earnings Per Share Expected for Ekso Bionics Holdings, Inc. (EKSO) This Quarter
www.americanbankingnews.com - April 13 at 11:17 PM
Nordson (NDSN) and Ekso Bionics (EKSO) Financial ContrastNordson (NDSN) and Ekso Bionics (EKSO) Financial Contrast
www.americanbankingnews.com - April 10 at 3:22 PM
Ekso Bionics (EKSO) versus Altra Industrial Motion (AIMC) Head to Head SurveyEkso Bionics (EKSO) versus Altra Industrial Motion (AIMC) Head to Head Survey
www.americanbankingnews.com - April 10 at 5:30 AM
Ekso Bionics (EKSO) Lowered to Hold at Zacks Investment ResearchEkso Bionics (EKSO) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - April 9 at 11:27 PM
Contrasting Altra Industrial Motion (AIMC) & Ekso Bionics (EKSO)Contrasting Altra Industrial Motion (AIMC) & Ekso Bionics (EKSO)
www.americanbankingnews.com - April 8 at 11:21 PM
Ekso Bionics (EKSO) & Nordson (NDSN) Head to Head ComparisonEkso Bionics (EKSO) & Nordson (NDSN) Head to Head Comparison
www.americanbankingnews.com - April 8 at 9:32 PM
Medical Bionics Market is Forecasted to Generate a Revenue of $28.1 Billion By 2023: P&S Market ResearchMedical Bionics Market is Forecasted to Generate a Revenue of $28.1 Billion By 2023: P&S Market Research
globenewswire.com - April 5 at 9:56 AM
Head-To-Head Contrast: Ekso Bionics (EKSO) vs. Altra Industrial Motion (AIMC)Head-To-Head Contrast: Ekso Bionics (EKSO) vs. Altra Industrial Motion (AIMC)
www.americanbankingnews.com - April 4 at 7:07 AM
Ekso Bionics (EKSO) versus Nordson (NDSN) Head-To-Head ReviewEkso Bionics (EKSO) versus Nordson (NDSN) Head-To-Head Review
www.americanbankingnews.com - April 4 at 7:07 AM
When Should You Buy Ekso Bionics Holdings Inc (NASDAQ:EKSO)?When Should You Buy Ekso Bionics Holdings Inc (NASDAQ:EKSO)?
finance.yahoo.com - March 30 at 8:09 AM
Medical Bionics Market is Expected to Reach US$ 36,818.2 Million By 2026: Credence ResearchMedical Bionics Market is Expected to Reach US$ 36,818.2 Million By 2026: Credence Research
globenewswire.com - March 28 at 8:15 AM
EKSO Leaps, FDA Nod For DRIO, CRVS Up 38% This Month, VTL To Report Data In Sep.EKSO Leaps, FDA Nod For DRIO, CRVS Up 38% This Month, VTL To Report Data In Sep.
www.finanznachrichten.de - March 27 at 8:15 AM
Pre-Market Technical Scan on Medical Supplies Equities -- Becton, Dickinson and Co., Ekso Bionics, Cooper, and Waters - PR Newswire (press release)Pre-Market Technical Scan on Medical Supplies Equities -- Becton, Dickinson and Co., Ekso Bionics, Cooper, and Waters - PR Newswire (press release)
www.prnewswire.com - March 19 at 8:10 AM
Edited Transcript of EKSO earnings conference call or presentation 13-Mar-18 8:30pm GMTEdited Transcript of EKSO earnings conference call or presentation 13-Mar-18 8:30pm GMT
finance.yahoo.com - March 18 at 8:08 AM
Ekso Bionics Reports Fourth Quarter and Year End 2017 Results - GlobeNewswire (press release)Ekso Bionics Reports Fourth Quarter and Year End 2017 Results - GlobeNewswire (press release)
www.globenewswire.com - March 14 at 8:15 AM
Ekso Bionics (EKSO) CEO Jack Peurach on Q4 2017 Results - Earnings Call Transcript - Seeking AlphaEkso Bionics' (EKSO) CEO Jack Peurach on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 14 at 8:15 AM
Robbins Arroyo LLP: Ekso Bionics Holdings, Inc. (EKSO) Misled ... - Business Wire (press release)Robbins Arroyo LLP: Ekso Bionics Holdings, Inc. (EKSO) Misled ... - Business Wire (press release)
www.businesswire.com - March 14 at 8:15 AM
Ekso Bionics Reports Fourth Quarter and Year End 2017 Results ... - GlobeNewswire (press release)Ekso Bionics Reports Fourth Quarter and Year End 2017 Results ... - GlobeNewswire (press release)
globenewswire.com - March 14 at 8:15 AM
Ekso Bionics Reports Fourth Quarter and Year End 2017 ResultsEkso Bionics Reports Fourth Quarter and Year End 2017 Results
finance.yahoo.com - March 13 at 7:26 PM
Was Ekso Bionics Holdings Inc’s (NASDAQ:EKSO) Earnings Growth Better Than The Industry’s?Was Ekso Bionics Holdings Inc’s (NASDAQ:EKSO) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - March 13 at 8:12 AM
Ekso Bionics Announces Executive Leadership Changes; Jack Peurach, co-founder of Ekso Bionics, long-time board ... - GlobeNewswire (press release)Ekso Bionics Announces Executive Leadership Changes; Jack Peurach, co-founder of Ekso Bionics, long-time board ... - GlobeNewswire (press release)
globenewswire.com - March 12 at 6:48 PM
Ekso Bionics (EKSO) Names Jack Peurach as President and CEO ... - StreetInsider.comEkso Bionics (EKSO) Names Jack Peurach as President and CEO ... - StreetInsider.com
www.streetinsider.com - March 12 at 6:48 PM
Ekso Bionics® to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 Ekso Bionics® to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 
finance.yahoo.com - March 6 at 5:47 PM
Ekso Bionics® to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 - GlobeNewswire (press release)Ekso Bionics® to Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018 - GlobeNewswire (press release)
globenewswire.com - March 6 at 8:06 AM
MARCH 5 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The FirmMARCH 5 DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm
finance.yahoo.com - February 28 at 6:10 PM
DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The FirmDEADLINE ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $100,000 To Contact The Firm
finance.yahoo.com - February 28 at 8:06 AM
FINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact The FirmFINAL DEADLINE ALERT:  Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) To Contact The Firm
finance.yahoo.com - February 27 at 6:02 PM
DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $50,000 To Contact The FirmDEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc. And Reminds Investors With Losses In Excess of $50,000 To Contact The Firm
finance.yahoo.com - February 26 at 5:51 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSOSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
finance.yahoo.com - February 24 at 8:05 AM
PLG Reminds Ekso Bionics Holdings, Inc. Investors of Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSOPLG Reminds Ekso Bionics Holdings, Inc. Investors of Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSO
finance.yahoo.com - February 23 at 6:06 PM
Zacks: Brokerages Anticipate Ekso Bionics Holdings, Inc. (EKSO) to Post -$0.10 EPSZacks: Brokerages Anticipate Ekso Bionics Holdings, Inc. (EKSO) to Post -$0.10 EPS
www.americanbankingnews.com - February 22 at 1:10 AM
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 14 at 3:40 PM
BRIEF-Ekso Bionics To Expand Clinical Trial Sites For Comparative Multicenter WISE StudyBRIEF-Ekso Bionics To Expand Clinical Trial Sites For Comparative Multicenter WISE Study
www.reuters.com - February 12 at 3:38 PM
EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Ekso Bionics Holdings, Inc. InvestorsEKSO INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
finance.yahoo.com - February 12 at 3:38 PM
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSOSHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ekso Bionics Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – EKSO
finance.yahoo.com - February 10 at 8:43 AM
Ekso Bionics Holdings, Inc. Reminder: Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSOEkso Bionics Holdings, Inc. Reminder: Important March 5, 2018 Lead Plaintiff Deadline in Class Action - EKSO
finance.yahoo.com - February 8 at 3:36 PM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO) - Business Wire (press release)Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO) - Business Wire (press release)
www.businesswire.com - February 8 at 8:05 AM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 8 at 8:05 AM
IMPORTANT EKSO BIONICS HOLDINGS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who suffered losses in Ekso Bionics Holdings, Inc.IMPORTANT EKSO BIONICS HOLDINGS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors who suffered losses in Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 8 at 8:05 AM
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 8 at 8:05 AM
Report: Exploring Fundamental Drivers Behind Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Communications, TAL Education Group, and Ekso Bionics — New Horizons, Emerging Trends, and Upcoming DevelopmentsReport: Exploring Fundamental Drivers Behind Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Communications, TAL Education Group, and Ekso Bionics — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - February 7 at 8:23 AM
Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO)Glancy Prongay & Murray LLP Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors (EKSO)
finance.yahoo.com - February 6 at 3:36 PM
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact the FirmDEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ekso Bionics Holdings, Inc. to Contact the Firm
finance.yahoo.com - February 6 at 8:25 AM
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.
finance.yahoo.com - February 5 at 3:35 PM
Ekso Bionics Holdings, Inc. (EKSO) Expected to Post Earnings of -$0.10 Per ShareEkso Bionics Holdings, Inc. (EKSO) Expected to Post Earnings of -$0.10 Per Share
www.americanbankingnews.com - February 5 at 1:10 AM
EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. InvestorsEKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
www.bizjournals.com - February 1 at 3:36 PM
EKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. InvestorsEKSO INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Ekso Bionics Holdings, Inc. Investors
finance.yahoo.com - February 1 at 3:36 PM
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Ekso Bionics Holdings, Inc. (EKSO) & Lead Plaintiff Deadline - March 5, 2018
finance.yahoo.com - February 1 at 3:36 PM

SEC Filings

Ekso Bionics (NASDAQ:EKSO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Ekso Bionics (NASDAQ EKSO) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.